Journal Reviews

MRI evaluation to assess the role of frusemide in reducing endolymphatic hydrops

1 July 2016 | | Diuretics, Endolymphatic Hydrops, Gadolinium, Magnetic Resonance Imaging

Endolymphatic hydrops is generally considered to be a marker in Ménière’s disease and frusemide is used with the purpose of reducing it and improving symptoms. With the use of MRI, the authors have used the phenomenon of non-enhancing endolymphatic structures...